Merck, Inc.

🇵🇭Philippines
Ownership
Subsidiary
Employees
-
Market Cap
$295.3B
Website
http://www.merck.ph
Clinical Trials
Related News

A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)

Phase 3
Completed
Conditions
Obesity
First Posted Date
2004-09-28
Last Posted Date
2015-01-30
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
359
Registration Number
NCT00092872

A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)

Phase 3
Completed
Conditions
Papillomavirus Infections
Human
Interventions
Biological: V501
First Posted Date
2004-09-28
Last Posted Date
2018-02-20
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
1781
Registration Number
NCT00092547

A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)

Phase 3
Completed
Conditions
Postoperative Pain
First Posted Date
2004-09-27
Last Posted Date
2017-05-09
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
251
Registration Number
NCT00092378

Dose Confirmation Efficacy Study (V260-007)

First Posted Date
2004-09-27
Last Posted Date
2015-09-14
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
1312
Registration Number
NCT00092443

A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)

Phase 3
Completed
Conditions
Osteoarthritis
First Posted Date
2004-09-27
Last Posted Date
2017-05-09
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
395
Registration Number
NCT00092352

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)

Phase 3
Completed
Conditions
Postoperative Pain
First Posted Date
2004-09-27
Last Posted Date
2016-02-22
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
269
Registration Number
NCT00092326

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)

Phase 3
Completed
Conditions
Postoperative Pain
First Posted Date
2004-09-27
Last Posted Date
2015-11-25
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
271
Registration Number
NCT00092313

Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

First Posted Date
2004-09-27
Last Posted Date
2015-01-13
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
3055
Registration Number
NCT00092495

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)

Phase 3
Completed
Conditions
Postoperative Pain
First Posted Date
2004-09-27
Last Posted Date
2017-05-09
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
125
Registration Number
NCT00092339

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)

Phase 2
Completed
Conditions
Rubella
Measles
Varicella
Mumps
First Posted Date
2004-09-27
Last Posted Date
2017-03-15
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
1210
Registration Number
NCT00092404
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy